{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ehrlich ascites carcinoma", "MTT assay", "antitumor activity", "nanocapsule", "pyridine derivatives"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37376202", "DateRevised": {"Year": "2023", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "16"}], "Language": ["eng"], "ELocationID": ["1755", "10.3390/pharmaceutics15061755"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "16"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives.", "Abstract": {"AbstractText": ["This study demonstrates high drug-loading of novel pyridine derivatives (S1-S4) in lipid- and polymer-based core-shell nanocapsules (LPNCs) for boosting the anticancer efficiency and alleviating toxicity of these novel pyridine derivatives. The nanocapsules were fabricated using a nanoprecipitation technique and characterized for particle size, surface morphology, and entrapment efficiency. The prepared nanocapsules exhibited a particle size ranging from 185.0 \u00b1 17.4 to 223.0 \u00b1 15.3 nm and a drug entrapment of >90%. The microscopic evaluation demonstrated spherical-shaped nanocapsules with distinct core-shell structures. The in vitro release study depicted a biphasic and sustained release pattern of test compounds from the nanocapsules. In addition, it was obvious from the cytotoxicity studies that the nanocapsules showed superior cytotoxicity against both MCF-7 and A549 cancer cell lines, as manifested by a significant decrease in the IC<sub>50</sub> value compared to free test compounds. The in vivo antitumor efficacy of the optimized nanocapsule formulation (S4-loaded LPNCs) was investigated in an Ehrlich ascites carcinoma (EAC) solid tumor-bearing mice model. Interestingly, the entrapment of the test compound (S4) within LPNCs remarkably triggered superior tumor growth inhibition when compared with either free S4 or the standard anticancer drug 5-fluorouracil. Such enhanced in vivo antitumor activity was accompanied by a remarkable increase in animal life span. Furthermore, the S4-loaded LPNC formulation was tolerated well by treated animals, as evidenced by the absence of any signs of acute toxicity or alterations in biochemical markers of liver and kidney functions. Collectively, our findings clearly underscore the therapeutic potential of S4-loaded LPNCs over free S4 in conquering EAC solid tumors, presumably via granting efficient delivery of adequate concentrations of the entrapped drug to the target site."]}, "AuthorList": [{"Identifier": ["0000-0001-7385-868X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt."}], "LastName": "Abu Lila", "ForeName": "Amr Selim", "Initials": "AS"}, {"Identifier": ["0000-0003-4150-7863"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Health Sciences, Thamar University, Thamar 87246, Yemen."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Al-Manara College for Medical Sciences, Maysan 62001, Iraq."}], "LastName": "Amran", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": ["0000-0003-4014-6074"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza 12622, Egypt."}, {"Identifier": [], "Affiliation": "Stem Cells Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Giza 12622, Egypt."}], "LastName": "Tantawy", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, Medicinal and Aromatic Plants Research Institute, National Center for Research, Khartoum 2404, Sudan."}], "LastName": "Moglad", "ForeName": "Ehssan H", "Initials": "EH"}, {"Identifier": ["0000-0001-7714-2267"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Gad", "ForeName": "Shadeed", "Initials": "S"}, {"Identifier": ["0000-0003-2821-9373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdul Rahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Alotaibi", "ForeName": "Hadil Faris", "Initials": "HF"}, {"Identifier": ["0000-0002-7532-6318"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Obaidullah", "ForeName": "Ahmad J", "Initials": "AJ"}, {"Identifier": ["0000-0002-3741-0893"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Khafagy", "ForeName": "El-Sayed", "Initials": "ES"}], "GrantList": [{"GrantID": "PSAU/2023/R/1444", "Agency": "Prince Sattam Bin Abdulaziz University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hassanpour S.H., Dehghani M. Review of cancer from perspective of molecular. J. Cancer Res. Pract. 2017;4:127\u2013129. doi: 10.1016/j.jcrpr.2017.07.001.", "ArticleIdList": ["10.1016/j.jcrpr.2017.07.001"]}, {"Citation": "Mahase E. Cancer overtakes CVD to become leading cause of death in high income countries. BMJ. 2019;366:l5368. doi: 10.1136/bmj.l5368.", "ArticleIdList": ["10.1136/bmj.l5368", "31481521"]}, {"Citation": "McCormack V.A., Boffetta P. Today\u2019s lifestyles, tomorrow\u2019s cancers: Trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann. Oncol. 2011;22:2349\u20132357. doi: 10.1093/annonc/mdq763.", "ArticleIdList": ["10.1093/annonc/mdq763", "21378201"]}, {"Citation": "Guimar\u00e3es D.S.M., de Sousa Luz L.S., do Nascimento S.B., Silva L.R., de Miranda Martins N.R., de Almeida H.G., de Souza Reis V., Maluf S.E.C., Budu A., Marinho J.A., et al. Improvement of antimalarial activity of a 3-alkylpiridine alkaloid analog by replacing the pyridine ring to a thiazole-containing heterocycle: Mode of action, mutagenicity profile, and Caco-2 cell-based permeability. Eur. J. Pharm. Sci. 2019;138:105015. doi: 10.1016/j.ejps.2019.105015.", "ArticleIdList": ["10.1016/j.ejps.2019.105015", "31344442"]}, {"Citation": "De S., Kumar S.K.A., Shah S.K., Kazi S., Sarkar N., Banerjee S., Dey S. Pyridine: The scaffolds with significant clinical diversity. RSC Adv. 2022;12:15385\u201315406. doi: 10.1039/D2RA01571D.", "ArticleIdList": ["10.1039/D2RA01571D", "PMC9121228", "35693235"]}, {"Citation": "Albratty M., Alhazmi H.A. Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review. Arab. J. Chem. 2022;15:103846. doi: 10.1016/j.arabjc.2022.103846.", "ArticleIdList": ["10.1016/j.arabjc.2022.103846"]}, {"Citation": "Lila A.S.A., Abdallah M.H., Khafagy E.-S., Shehata T.M., Soliman M.S., Younes K.M., Omran M.M., Gad S. Design, synthesis and cytotoxic evaluation of 2-amino-4- aryl-6-substituted pyridine-3,5-dicarbonitrile derivatives. Trop. J. Pharm. Res. 2021;20:2127\u20132133. doi: 10.4314/tjpr.v20i10.16.", "ArticleIdList": ["10.4314/tjpr.v20i10.16"]}, {"Citation": "Rizvi S.A.A., Saleh A.M. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J. 2018;26:64\u201370. doi: 10.1016/j.jsps.2017.10.012.", "ArticleIdList": ["10.1016/j.jsps.2017.10.012", "PMC5783816", "29379334"]}, {"Citation": "Patra J.K., Das G., Fraceto L.F., Campos E.V.R., Rodriguez-Torres M.D.P., Acosta-Torres L.S., Diaz-Torres L.A., Grillo R., Swamy M.K., Sharma S., et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018;16:71. doi: 10.1186/s12951-018-0392-8.", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Mitchell M.J., Billingsley M.M., Haley R.M., Wechsler M.E., Peppas N.A., Langer R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 2021;20:101\u2013124. doi: 10.1038/s41573-020-0090-8.", "ArticleIdList": ["10.1038/s41573-020-0090-8", "PMC7717100", "33277608"]}, {"Citation": "Ghosh B., Biswas S. Polymeric micelles in cancer therapy: State of the art. J. Control. Release. 2021;332:127\u2013147. doi: 10.1016/j.jconrel.2021.02.016.", "ArticleIdList": ["10.1016/j.jconrel.2021.02.016", "33609621"]}, {"Citation": "Abu Lila A.S., Ishida T., Kiwada H. Recent advances in tumor vasculature targeting using liposomal drug delivery systems. Expert Opin. Drug Deliv. 2009;6:1297\u20131309. doi: 10.1517/17425240903289928.", "ArticleIdList": ["10.1517/17425240903289928", "19780711"]}, {"Citation": "Mundekkad D., Cho W.C. Nanoparticles in Clinical Translation for Cancer Therapy. Int. J. Mol. Sci. 2022;23:1685. doi: 10.3390/ijms23031685.", "ArticleIdList": ["10.3390/ijms23031685", "PMC8835852", "35163607"]}, {"Citation": "Bober Z., Bartusik-Aebisher D., Aebisher D. Application of Dendrimers in Anticancer Diagnostics and Therapy. Molecules. 2022;27:3237. doi: 10.3390/molecules27103237.", "ArticleIdList": ["10.3390/molecules27103237", "PMC9144149", "35630713"]}, {"Citation": "Montan\u00e9 X., Bajek A., Roszkowski K., Montorn\u00e9s J.M., Giamberini M., Roszkowski S., Kowalczyk O., Garcia-Valls R., Tylkowski B. Encapsulation for Cancer Therapy. Molecules. 2020;25:1605. doi: 10.3390/molecules25071605.", "ArticleIdList": ["10.3390/molecules25071605", "PMC7180689", "32244513"]}, {"Citation": "Kothamasu P., Kanumur H., Ravur N., Maddu C., Parasuramrajam R., Thangavel S. Nanocapsules: The weapons for novel drug delivery systems. Bioimpacts. 2012;2:71\u201381. doi: 10.5681/bi.2012.011.", "ArticleIdList": ["10.5681/bi.2012.011", "PMC3648923", "23678444"]}, {"Citation": "Yurgel V., Collares T., Seixas F. Developments in the use of nanocapsules in oncology. Braz. J. Med. Biol. Res. 2013;46:486\u2013501. doi: 10.1590/1414-431X20132643.", "ArticleIdList": ["10.1590/1414-431X20132643", "PMC3854440", "23802234"]}, {"Citation": "Huynh N.T., Passirani C., Saulnier P., Benoit J.P. Lipid nanocapsules: A new platform for nanomedicine. Int. J. Pharm. 2009;379:201\u2013209. doi: 10.1016/j.ijpharm.2009.04.026.", "ArticleIdList": ["10.1016/j.ijpharm.2009.04.026", "19409468"]}, {"Citation": "Moura R.P., Pacheco C., P\u00eago A.P., des Rieux A., Sarmento B. Lipid nanocapsules to enhance drug bioavailability to the central nervous system. J. Control. Release. 2020;322:390\u2013400. doi: 10.1016/j.jconrel.2020.03.042.", "ArticleIdList": ["10.1016/j.jconrel.2020.03.042", "32247807"]}, {"Citation": "B\u00e9duneau A., Saulnier P., Hindr\u00e9 F., Clavreul A., Leroux J.-C., Benoit J.-P. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab\u2019 fragments. Biomaterials. 2007;28:4978\u20134990. doi: 10.1016/j.biomaterials.2007.05.014.", "ArticleIdList": ["10.1016/j.biomaterials.2007.05.014", "17716725"]}, {"Citation": "Figueir\u00f3 F., de Oliveira C.P., Rockenbach L., Mendes F.B., Bergamin L.S., Jandrey E.H., Edelweiss M.I., Guterres S.S., Pohlmann A.R., Battastini A.M. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model. J. Biomed. Nanotechnol. 2015;11:1808\u20131818. doi: 10.1166/jbn.2015.2125.", "ArticleIdList": ["10.1166/jbn.2015.2125", "26502643"]}, {"Citation": "Bernardi A., Frozza R.L., Hoppe J.B., Salbego C., Pohlmann A.R., Battastini A.M., Guterres S.S. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways. Int. J. Nanomed. 2013;8:711\u2013728. doi: 10.2147/IJN.S40284.", "ArticleIdList": ["10.2147/IJN.S40284", "PMC3578504", "23440594"]}, {"Citation": "Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989;55:R1\u2013R4. doi: 10.1016/0378-5173(89)90281-0.", "ArticleIdList": ["10.1016/0378-5173(89)90281-0"]}, {"Citation": "Molaahmadi M.R., Varshosaz J., Taymouri S., Akbari V. Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity against Melanoma Cell Line. Iran. J. Pharm. Res. 2019;18:1676\u20131693. doi: 10.22037/ijpr.2019.1100870.", "ArticleIdList": ["10.22037/ijpr.2019.1100870", "PMC7059069", "32184838"]}, {"Citation": "Moin A., Wani S.U.D., Osmani R.A., Abu Lila A.S., Khafagy E.S., Arab H.H., Gangadharappa H.V., Allam A.N. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer. Drug Deliv. 2021;28:1626\u20131636. doi: 10.1080/10717544.2021.1958106.", "ArticleIdList": ["10.1080/10717544.2021.1958106", "PMC8330732", "34328806"]}, {"Citation": "Akhila J.S., Shyamjith D., Alwar M.C. Acute toxicity studies and determination of median lethal dose. Curr. Sci. 2007;93:917\u2013920."}, {"Citation": "Chinedu E., Arome D., Ameh F.S. A new method for determining acute toxicity in animal models. Toxicol. Int. 2013;20:224\u2013226. doi: 10.4103/0971-6580.121674.", "ArticleIdList": ["10.4103/0971-6580.121674", "PMC3877490", "24403732"]}, {"Citation": "He Y.C., Chen J.W., Cao J., Pan D.Y., Qiao J.G. Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. World J. Gastroenterol. 2003;9:1795\u20131798. doi: 10.3748/wjg.v9.i8.1795.", "ArticleIdList": ["10.3748/wjg.v9.i8.1795", "PMC4611546", "12918123"]}, {"Citation": "Amr A.E.E., Ibrahimd A.A., El-Shehry M.F., Hosni H.M., Fayed A.A., Elsayed E.A. In Vitro and In Vivo Anti-Breast Cancer Activities of Some Newly Synthesized 5-(thiophen-2-yl)thieno-[2,3-d]pyrimidin-4-one Candidates. Molecules. 2019;24:2255. doi: 10.3390/molecules24122255.", "ArticleIdList": ["10.3390/molecules24122255", "PMC6631792", "31212962"]}, {"Citation": "Mohamed S.F., Hosni H.M., Amr A.E.-G.E., Abdalla M.M. Synthesis of novel substituted pyridines from 1-(3-aminophenyl)-3-(1H-indol-3-yl)prop-2-en-1-one and their anticancer activity. Russ. J. Gen. Chem. 2016;86:672\u2013680. doi: 10.1134/S1070363216030269.", "ArticleIdList": ["10.1134/S1070363216030269"]}, {"Citation": "Hather G., Liu R., Bandi S., Mettetal J., Manfredi M., Shyu W.C., Donelan J., Chakravarty A. Growth rate analysis and efficient experimental design for tumor xenograft studies. Cancer Inf. 2014;13:65\u201372. doi: 10.4137/CIN.S13974.", "ArticleIdList": ["10.4137/CIN.S13974", "PMC4264612", "25574127"]}, {"Citation": "Abu Lila A.S., Kizuki S., Doi Y., Suzuki T., Ishida T., Kiwada H. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J. Control. Release. 2009;137:8\u201314. doi: 10.1016/j.jconrel.2009.02.023.", "ArticleIdList": ["10.1016/j.jconrel.2009.02.023", "19285528"]}, {"Citation": "Alotaibi B., Tousson E., El-Masry T.A., Altwaijry N., Saleh A. Ehrlich ascites carcinoma as model for studying the cardiac protective effects of curcumin nanoparticles against cardiac damage in female mice. Environ. Toxicol. 2021;36:105\u2013113. doi: 10.1002/tox.23016.", "ArticleIdList": ["10.1002/tox.23016", "32865349"]}, {"Citation": "Reitman S., Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 1957;28:56\u201363. doi: 10.1093/ajcp/28.1.56.", "ArticleIdList": ["10.1093/ajcp/28.1.56", "13458125"]}, {"Citation": "Nicolas S., Bolzinger M.A., Jordheim L.P., Chevalier Y., Fessi H., Almouazen E. Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells. Int. J. Pharm. 2018;550:170\u2013179. doi: 10.1016/j.ijpharm.2018.08.022.", "ArticleIdList": ["10.1016/j.ijpharm.2018.08.022", "30118832"]}, {"Citation": "Moinard-Ch\u00e9cot D., Chevalier Y., Brian\u00e7on S., Beney L., Fessi H. Mechanism of nanocapsules formation by the emulsion\u2013diffusion process. J. Colloid Interface Sci. 2008;317:458\u2013468. doi: 10.1016/j.jcis.2007.09.081.", "ArticleIdList": ["10.1016/j.jcis.2007.09.081", "17936772"]}, {"Citation": "Kim M.W., Kwon S.-H., Choi J.H., Lee A. A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy. Int. J. Mol. Sci. 2018;19:3859. doi: 10.3390/ijms19123859.", "ArticleIdList": ["10.3390/ijms19123859", "PMC6321581", "30518027"]}, {"Citation": "Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015;33:941\u2013951. doi: 10.1038/nbt.3330.", "ArticleIdList": ["10.1038/nbt.3330", "PMC4978509", "26348965"]}, {"Citation": "Nicolete R., dos Santos D.F., Faccioli L.H. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. Int. Immunopharmacol. 2011;11:1557\u20131563. doi: 10.1016/j.intimp.2011.05.014.", "ArticleIdList": ["10.1016/j.intimp.2011.05.014", "21621649"]}, {"Citation": "Singh E., Osmani R.A.M., Banerjee R., Abu Lila A.S., Moin A., Almansour K., Arab H.H., Alotaibi H.F., Khafagy E.S. Poly \u03b5-Caprolactone Nanoparticles for Sustained Intra-Articular Immune Modulation in Adjuvant-Induced Arthritis Rodent Model. Pharmaceutics. 2022;14:519. doi: 10.3390/pharmaceutics14030519.", "ArticleIdList": ["10.3390/pharmaceutics14030519", "PMC8953799", "35335895"]}, {"Citation": "Soliman W.E., Khan S., Rizvi S.M.D., Moin A., Elsewedy H.S., Abulila A.S., Shehata T.M. Therapeutic Applications of Biostable Silver Nanoparticles Synthesized Using Peel Extract of Benincasa hispida: Antibacterial and Anticancer Activities. Nanomaterials. 2020;10:1954. doi: 10.3390/nano10101954.", "ArticleIdList": ["10.3390/nano10101954", "PMC7600797", "33008104"]}, {"Citation": "Tavares E.J.M., Ara\u00fajo D.R.d., Fraceto L.F. Ivermectin-loaded polymeric nanoparticles: Screening the effects of polymers, methods, and the usefulness of mathematical models. J. Nanosci. Nanotechnol. 2017;17:4218\u20134234. doi: 10.1166/jnn.2017.13111.", "ArticleIdList": ["10.1166/jnn.2017.13111"]}, {"Citation": "Al Saqr A., Khafagy E.S., Alalaiwe A., Aldawsari M.F., Alshahrani S.M., Anwer M.K., Khan S., Lila A.S.A., Arab H.H., Hegazy W.A.H. Synthesis of Gold Nanoparticles by Using Green Machinery: Characterization and In Vitro Toxicity. Nanomaterials. 2021;11:808. doi: 10.3390/nano11030808.", "ArticleIdList": ["10.3390/nano11030808", "PMC8004202", "33809859"]}, {"Citation": "De Melo N.F., Grillo R., Guilherme V.A., de Araujo D.R., de Paula E., Rosa A.H., Fraceto L.F. Poly(lactide-co-glycolide) nanocapsules containing benzocaine: Influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. Pharm. Res. 2011;28:1984\u20131994. doi: 10.1007/s11095-011-0425-6.", "ArticleIdList": ["10.1007/s11095-011-0425-6", "21472490"]}, {"Citation": "Liu G., McEnnis K. Glass Transition Temperature of PLGA Particles and the Influence on Drug Delivery Applications. Polymers. 2022;14:993. doi: 10.3390/polym14050993.", "ArticleIdList": ["10.3390/polym14050993", "PMC8912735", "35267816"]}, {"Citation": "Chen C.K., Law W.C., Aalinkeel R., Yu Y., Nair B., Wu J., Mahajan S., Reynolds J.L., Li Y., Lai C.K., et al. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. Nanoscale. 2014;6:1567\u20131572. doi: 10.1039/C3NR04804G.", "ArticleIdList": ["10.1039/C3NR04804G", "PMC4522154", "24326457"]}, {"Citation": "Sethi M., Sukumar R., Karve S., Werner M.E., Wang E.C., Moore D.T., Kowalczyk S.R., Zhang L., Wang A.Z. Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity. Nanoscale. 2014;6:2321\u20132327. doi: 10.1039/C3NR05961H.", "ArticleIdList": ["10.1039/C3NR05961H", "PMC3940272", "24418914"]}, {"Citation": "Giannini E.G., Testa R., Savarino V. Liver enzyme alteration: A guide for clinicians. CMAJ. 2005;172:367\u2013379. doi: 10.1503/cmaj.1040752.", "ArticleIdList": ["10.1503/cmaj.1040752", "PMC545762", "15684121"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "22"}, {"Year": "2023", "Month": "6", "Day": "10"}, {"Year": "2023", "Month": "6", "Day": "15"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "1", "Minute": "37"}, {"Year": "2023", "Month": "6", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["37376202", "PMC10304225", "10.3390/pharmaceutics15061755", "pharmaceutics15061755"]}}], "PubmedBookArticle": []}